CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing

被引:747
|
作者
Montague, Tessa G. [1 ]
Cruz, Jose M. [2 ,3 ]
Gagnon, James A. [1 ]
Church, George M. [3 ,4 ]
Valen, Eivind [1 ]
机构
[1] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[2] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA
[3] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA
[4] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
关键词
HUMAN-CELLS; CRISPR-CAS9; SYSTEM; XENOPUS-TROPICALIS; CAS9; NUCLEASE; DESIGN TOOL; SPECIFICITY; MUTAGENESIS; DROSOPHILA; EFFECTORS; GENES;
D O I
10.1093/nar/gku410
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Major advances in genome editing have recently been made possible with the development of the TALEN and CRISPR/Cas9 methods. The speed and ease of implementing these technologies has led to an explosion of mutant and transgenic organisms. A rate-limiting step in efficiently applying TALEN and CRISPR/Cas9 methods is the selection and design of targeting constructs. We have developed an online tool, CHOPCHOP (https://chopchop.rc.fas.harvard.edu), to expedite the design process. CHOPCHOP accepts a wide range of inputs (gene identifiers, genomic regions or pasted sequences) and provides an array of advanced options for target selection. It uses efficient sequence alignment algorithms to minimize search times, and rigorously predicts off-target binding of single-guide RNAs (sgRNAs) and TALENs. Each query produces an interactive visualization of the gene with candidate target sites displayed at their genomic positions and color-coded according to quality scores. In addition, for each possible target site, restriction sites and primer candidates are visualized, facilitating a streamlined pipeline of mutant generation and validation. The ease-of-use and speed of CHOPCHOP make it a valuable tool for genome engineering.
引用
收藏
页码:W401 / W407
页数:7
相关论文
共 50 条
  • [21] Advances in therapeutic CRISPR/Cas9 genome editing
    Schwank, G.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1053 - 1053
  • [22] CRISPR/CAS9: THE GOLD STANDARD OF GENOME EDITING?
    Gleeson, Alfie
    Sawyer, Abigail
    BIOTECHNIQUES, 2018, 64 (06) : 239 - 244
  • [23] CRISPR/CAS9, the King of Genome Editing Tools
    Bannikov, A. V.
    Lavrov, A. V.
    MOLECULAR BIOLOGY, 2017, 51 (04) : 514 - 525
  • [24] CRISPR/Cas9 and other techniques for genome editing
    Hartung, Frank
    Schiemann, Jochen
    Sprink, Thorben
    ZWEITES SYMPOSIUM ZIERPFLANZENZUCHTUNG, 2017, 2017, 457 : 36 - 39
  • [25] Genome Editing in Cotton with the CRISPR/Cas9 System
    Gao, Wei
    Long, Lu
    Tian, Xinquan
    Xu, Fuchun
    Liu, Ji
    Singh, Prashant K.
    Botella, Jose R.
    Song, Chunpeng
    FRONTIERS IN PLANT SCIENCE, 2017, 8
  • [26] Advances in therapeutic CRISPR/Cas9 genome editing
    Savic, Natasa
    Schwank, Gerald
    TRANSLATIONAL RESEARCH, 2016, 168 : 15 - 21
  • [27] Translating CRISPR/Cas9 genome editing into therapeutics
    Barnes, T. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A140 - A141
  • [28] A glance at genome editing with CRISPR–Cas9 technology
    Antara Barman
    Bornali Deb
    Supriyo Chakraborty
    Current Genetics, 2020, 66 : 447 - 462
  • [29] CRISPR/Cas9: Transcending the Reality of Genome Editing
    Chira, Sergiu
    Gulei, Diana
    Hajitou, Amin
    Zimta, Alina-Andreea
    Cordelier, Pierre
    Berindan-Neagoe, Ioana
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 7 : 211 - 222
  • [30] Efficient Mitochondrial Genome Editing by CRISPR/Cas9
    Jo, Areum
    Ham, Sangwoo
    Lee, Gum Hwa
    Lee, Yun-Il
    Kim, SangSeong
    Lee, Yun-Song
    Shin, Joo-Ho
    Lee, Yunjong
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015